Amy E. Herr - 14 Feb 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
Director
Issuer ticker
TECH
Reported as of
14 Feb 2025
Net transaction value
-$35,095
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2025, 16:49:57 UTC
Prior SEC filing
07 Feb 2025
Next SEC filing
11 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney previously filed

Key filing fact

Amy E. Herr filed Form 4 for BIO-TECHNE Corp (TECH) on 18 Feb 2025.

Key facts

  • This page summarizes Amy E. Herr's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2025, 16:49.

Change

  • Previous filing in this sequence was filed on 07 Feb 2025.
  • Current net transaction value: -$35,095.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$87,596
Shares
+1,976
Change %
+106%
Price
$44.33
Shares after
3,836
Date
14 Feb 2025
Ownership
By significant other
TECH transaction

Common Stock

Sale

Transaction value
$122,691
Shares
-1,860
Change %
-48%
Price
$65.96
Shares after
1,976
Date
14 Feb 2025
Ownership
By significant other
TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,040
Date
14 Feb 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,976
Change %
-61%
Price
$0.000000
Shares after
1,280
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
3,256
Exercise price
$44.33
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,415
Date
14 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,415
Exercise price
$72.05
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,636
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
6,636
Exercise price
$47.60
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,472
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
4,472
Exercise price
$66.97
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,076
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
2,076
Exercise price
$120.46
Footnotes
F3
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,104
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
2,104
Exercise price
$94.52
Footnotes
F4
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,084
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
1,084
Exercise price
$84.61
Footnotes
F5
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,468
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
1,468
Exercise price
$74.91
Footnotes
F6
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
344
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
344
Exercise price
$72.05
Footnotes
F7
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
237
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
237
Exercise price
Footnotes
F8, F9
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
480
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
480
Exercise price
Footnotes
F8, F10
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
115
Date
14 Feb 2025
Ownership
By significant other
Underlying class
Common Stock
Underlying amount
115
Exercise price
Footnotes
F8, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.

Footnote F2

Fully vested.

Footnote F3

520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.

Footnote F4

528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.

Footnote F5

271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.

Footnote F6

367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F7

86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.

Footnote F8

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F9

119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.

Footnote F10

160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.

Footnote F11

38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .